Quan Anh Vu's most recent trade in Monopar Therapeutics Inc was a trade of 25,000 Stock Options done . Disclosure was reported to the exchange on March 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Monopar Therapeutics Inc | Quan Anh Vu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,000 | 25,000 | - | - | Stock Options | |
180 Life Sciences Corp | Quan Anh Vu | COO / Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 16 Dec 2021 | 8,000 | 20,500 | - | 4.0 | 31,840 | Common Stock |
180 Life Sciences Corp | Quan Anh Vu | COO / Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 3.90 per share. | 10 Dec 2021 | 4,500 | 12,500 | - | 3.9 | 17,550 | Common Stock |
180 Life Sciences Corp | Quan Anh Vu | COO / Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) |